Creger RJ, Cowan RI, Nearman HS, Blumer JL, Selman WR, Danziger LH. Cerebrospinal fluid penetration of moxalactam in ventriculostomy patients.
Antimicrob Agents Chemother 1985;
28:839-41. [PMID:
4083867 PMCID:
PMC180342 DOI:
10.1128/aac.28.6.839]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
The cerebrospinal fluid penetration of moxalactam was simultaneously investigated in three patients with presumed bacterial meningitis. When ratios of simultaneously drawn ventriculostomy to serum moxalactam levels of 1, 2, 3, and 4 h were examined, the penetration ratios were 7.8 +/- 2.4, 11.2 +/- 1.3, 14.2 +/- 2.5, and 15.0 +/- 4.9%, respectively. These ratios were not statistically different from the penetration of moxalactam calculated by the area under the concentration-time curve technique (8.97 +/- 1.89%).
Collapse